UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells

Leukemia, 2018-04, Vol.32 (4), p.1003-1015

2018

Volltextzugriff (PDF)

Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis

ESMO open, 2022-06, Vol.7 (3), p.100465-100465, Article 100465

2022

Volltextzugriff (PDF)

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

Annals of oncology, 2011-05, Vol.22 (5), p.1141-1146

2011

Volltextzugriff (PDF)

A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival

Blood cancer journal (New York), 2016-12, Vol.6 (12), p.e511-e511

2016

Volltextzugriff (PDF)

Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro

International journal of cancer, 2012-04, Vol.130 (7), p.1577-1589

2012

Volltextzugriff (PDF)

HLA-DrbB1 heterozygosis and early auto-antibody rise predict prolonged survival in metastatic NSCLC patients undergoing PD-1 blockade

Annals of oncology, 2018-10, Vol.29, p.viii510-viii510

2018

Volltextzugriff (PDF)

Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients

Cell death discovery, 2016-10, Vol.2 (1), p.16025-16025, Article 16025

2016

Volltextzugriff (PDF)

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response

Cell death & disease, 2016-07, Vol.7 (7), p.e2299-e2299

2016

Volltextzugriff (PDF)

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

ESMO open, 2024-08, Vol.9 (8), p.103650, Article 103650

2024

Volltextzugriff (PDF)

31INIMMUNOTHERAPY AND VACCINES

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv12-iv13

Correale, P.

2014

Volltextzugriff (PDF)

Immunotherapy and Vaccines

Annals of oncology, 2014-09, Vol.25, p.iv12

Correale, P.

2014

Volltextzugriff (PDF)

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

Oncology reports, 2006-07, Vol.16 (1), p.133-140

2006

Volltextzugriff (PDF)

9135 POSTER Immune-modulating Effects of Bevacizumab and Metronomic Platinum Based-chemotherapy in Advanced Non-small-cell-lung Cancer (NSCLC) Patients

European journal of cancer (1990), 2011, Vol.47, p.S634-S634

2011

Volltextzugriff (PDF)

4199 POSTER Early Psychological Intervention in Cancer Patients: Effects on Emotional Distress

European journal of cancer (1990), 2011, Vol.47, p.S308-S308

2011

Volltextzugriff (PDF)

In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific Antigen

JNCI : Journal of the National Cancer Institute, 1997-02, Vol.89 (4), p.293-300

1997

Volltextzugriff (PDF)

1418 POSTER Baseline Inflammatory Status Defined by Neutrophil to Lymphocyte Cell Count Ratio (NLR) Predicts Progression Free Survival (PFS) in Metastatic Colorectal Cancer Patients (mCRC) Undergoing Bevacizumab Based Biochemotherapy

European journal of cancer (1990), 2011, Vol.47, p.S174-S175

2011

Volltextzugriff (PDF)

1439 POSTER Treatment-related Changes in Systemic Inflammatory Status, Measured by Neutrophil-to-lymphocyte Ratio, is Predictive of Outcome in Metastatic Colorectal Cancer Patients

European journal of cancer (1990), 2011, Vol.47, p.S181-S181

2011

Volltextzugriff (PDF)

6106 POSTER Immune-boost Treatment With Gemcitabine, Oxaliplatin, Levofolinate, 5-flurouracil, Granulocyte/macrophage Colony-stimulating-factor (GM-CSF) and Aldesleukine Enhances Progression-free and Overall-survival Over FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients – Early Results From the GOLFIG-2 Phase III Trial

European journal of cancer (1990), 2011, Vol.47, p.S424-S424

2011

Volltextzugriff (PDF)

Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate

Journal of chemotherapy (Florence), 2010-06, Vol.22 (3), p.201-204

2010

Volltextzugriff (PDF)

Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide

The Journal of immunology (1950), 1998-09, Vol.161 (6), p.3186-3194

1998

Volltextzugriff (PDF)

6140 POSTER Cetuximab-mediated Immune-enhancing Effects in Vitro and in Metastatic Colorectal Cancer (mCRC) Patients

European journal of cancer (1990), 2011, Vol.47, p.S434-S434

2011

Volltextzugriff (PDF)

PO-1528 Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak

Radiotherapy and oncology, 2021-08, Vol.161, p.S1252-S1253

2021

Volltextzugriff (PDF)

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

Journal of immunotherapy, 2010-05, Vol.33 (4), p.435-441

2010

Volltextzugriff (PDF)

Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation

British journal of cancer, 2007-05, Vol.96 (9), p.1343-1347

2007

Volltextzugriff (PDF)

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

British journal of cancer, 2004-05, Vol.90 (9), p.1710-1714

2004

Volltextzugriff (PDF)

1 – 25 von 328

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(277)
Mit Volltextzugriff
(256)

Publikationsform

Artikel
(325)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells

Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis

Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients

A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival

Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro

HLA-DrbB1 heterozygosis and early auto-antibody rise predict prolonged survival in metastatic NSCLC patients undergoing PD-1 blockade

Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response

Efficacy of adjuvant chemotherapy schedules for breast cancer according to body mass index: results from the phase III GIM2 trial

31INIMMUNOTHERAPY AND VACCINES

Immunotherapy and Vaccines

A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients

9135 POSTER Immune-modulating Effects of Bevacizumab and Metronomic Platinum Based-chemotherapy in Advanced Non-small-cell-lung Cancer (NSCLC) Patients

4199 POSTER Early Psychological Intervention in Cancer Patients: Effects on Emotional Distress

In Vitro Generation of Human Cytotoxic T Lymphocytes Specific for Peptides Derived From Prostate-Specific Antigen

1418 POSTER Baseline Inflammatory Status Defined by Neutrophil to Lymphocyte Cell Count Ratio (NLR) Predicts Progression Free Survival (PFS) in Metastatic Colorectal Cancer Patients (mCRC) Undergoing Bevacizumab Based Biochemotherapy

1439 POSTER Treatment-related Changes in Systemic Inflammatory Status, Measured by Neutrophil-to-lymphocyte Ratio, is Predictive of Outcome in Metastatic Colorectal Cancer Patients

Oral Metronomic Chemo-Hormonal-Therapy of Metastatic Breast Cancer with Cyclophosphamide and Megestrol Acetate

Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide

6140 POSTER Cetuximab-mediated Immune-enhancing Effects in Vitro and in Metastatic Colorectal Cancer (mCRC) Patients

PO-1528 Mood disorder in cancer patients undergoing radiotherapy during the COVID-19 outbreak

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy

Chemo-hormone therapy of non-well-differentiated endocrine tumours from different anatomic sites with cisplatinum, etoposide and slow release lanreotide formulation

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

Suchergebnisse filtern